Showing results (171-180 of 183) with videos related to
Sort By:
Pageof 19
European Annals of Otorhinolaryngology, Head and Neck Diseases|January 1, 2013
Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part 2: Remote extension assessment and exploration for secondary synchronous locations outside of the upper aerodigestive tract. 2012 SFORL guidelinesE de Monès, C Bertolus, P Y Salaun, et al.Journal of Medicinal Chemistry|February 11, 2017
"Addition" and "Subtraction": Selectivity Design for Type II Maternal Embryonic Leucine Zipper Kinase InhibitorsXin Chen, John Giraldes, Elizabeth R Sprague, et al.American Journal of Respiratory Cell and Molecular Biology|October 7, 2006
Efficacy of IL-13 neutralization in a sheep model of experimental asthmaMarion T Kasaian, Debra D Donaldson, Lioudmila Tchistiakova, et al.Neurology|January 13, 2012
FLNA genomic rearrangements cause periventricular nodular heterotopiaK R Clapham, T W Yu, V S Ganesh, et al.Diabetologia|July 19, 2008
A copper(II)-selective chelator ameliorates diabetes-evoked renal fibrosis and albuminuria, and suppresses pathogenic TGF-beta activation in the kidneys of rats used as a model of diabetesD Gong, J Lu, X Chen, et al.European Annals of Otorhinolaryngology, Head and Neck Diseases|January 26, 2013
Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part I: Locoregional extension assessment: 2012 SFORL guidelinesS Vergez, S Morinière, F Dubrulle, et al.ACS Medicinal Chemistry Letters|June 6, 2014
The role of the acidity of N-heteroaryl sulfonamides as inhibitors of bcl-2 family protein-protein interactionsB Barry Touré, Karen Miller-Moslin, Naeem Yusuff, et al.Structure (London, England : 1993)|January 31, 2017
Allosteric Mutant IDH1 Inhibitors Reveal Mechanisms for IDH1 Mutant and Isoform SelectivityXiaoling Xie, Daniel Baird, Kimberly Bowen, et al.Journal of Medicinal Chemistry|May 18, 2016
Toward the Validation of Maternal Embryonic Leucine Zipper Kinase: Discovery, Optimization of Highly Potent and Selective Inhibitors, and Preliminary Biology InsightB Barry Touré, John Giraldes, Troy Smith, et al.ACS Medicinal Chemistry Letters|February 16, 2017
Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Allosteric and Mutant Specific Inhibitors of IDH1Julian R Levell, Thomas Caferro, Gregg Chenail, et al.Pageof 19